Differential effect of psychotropic drugs on dihydroxyphenylacetic acid (DOPAC) in the rat substantia nigra and caudate nucleus.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism*; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D002421:Caudate Nucleus / Q000378:metabolism*; D003913:Dextroamphetamine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D006220:Haloperidol / Q000494:pharmacology; D008297:Male; D010293:Pargyline / Q000494:pharmacology; D010648:Phenylacetates / Q000378:metabolism*; D011619:Psychotropic Drugs / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013378:Substantia Nigra / Q000378:metabolism*
D010648:Phenylacetates; D011619:Psychotropic Drugs; D015102:3,4-Dihydroxyphenylacetic Acid; D012110:Reserpine; D010293:Pargyline; D006220:Haloperidol; D001058:Apomorphine; D003913:Dextroamphetamine; D004298:Dopamine